Cheng Nitao, Chen Chen, Liu Junliang, Wang Xuanchun, Gao Ziqi, Mao Ming, Huang Jingyu
Department of Thoracic Surgery, Central South Hospital, Wuhan University, Wuhan, China.
Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Curr Gene Ther. 2025;25(4):559-565. doi: 10.2174/0115665232312364240902060458.
Lung cancer stands as one of the most prevalent malignant neoplasms, with microRNAs (miRNAs) playing a pivotal role in the modulation of gene expression, impacting cancer cell proliferation, invasion, metastasis, immune escape, and resistance to therapy.
The intricate role of miRNAs in lung cancer underscores their significance as biomarkers for early detection and as novel targets for therapeutic intervention. Traditional approaches for the identification of miRNAs related to lung cancer, however, are impeded by inefficiencies and complexities.
In response to these challenges, this study introduced an innovative deep-learning strategy designed for the efficient and precise identification of lung cancer-associated miRNAs. Through comprehensive benchmark tests, our method exhibited superior performance relative to existing technologies.
Further case studies have also confirmed the ability of our model to identify lung cancer- associated miRNAs that have undergone biological validation.
肺癌是最常见的恶性肿瘤之一,微小RNA(miRNA)在基因表达调控中起关键作用,影响癌细胞的增殖、侵袭、转移、免疫逃逸和对治疗的抗性。
miRNA在肺癌中的复杂作用凸显了它们作为早期检测生物标志物和治疗干预新靶点的重要性。然而,传统的鉴定与肺癌相关miRNA的方法存在效率低下和复杂性的问题。
针对这些挑战,本研究引入了一种创新的深度学习策略,用于高效、精确地鉴定与肺癌相关的miRNA。通过全面的基准测试,我们的方法相对于现有技术表现出卓越的性能。
进一步的案例研究也证实了我们的模型能够鉴定经过生物学验证的与肺癌相关的miRNA。